Article
Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types. Körmöczi GF, Förstemann E, Gabriel C, Mayr WR, Schönitzer D, Gassner C. Transfusion, 2005. [Citation]
Remark: including sample also included in
Annotations by Allele
- RHD*1121A (weak D type 32): Serology (Table 2)
- RHD*1121A (weak D type 32): Density
- RHD*1121A (weak D type 32): otherHaplotype
- RHD*1121A (weak D type 32): Prevalence
- RHD*1121A (weak D type 32): otherHaplotype
- RHD*1121A (weak D type 32): RH1
- RHD*1121A (weak D type 32): RH1 (adsorption-elution was performed; DCCee sample with probable suppressive effect of C in trans)
- RHD*1121A (weak D type 32): RH1 (initially typed as D negative)
- RHD*1154C (weak D type 2): otherHaplotype (2 samples used as controls, may have been included in other studies)
- RHD*1154C (weak D type 2): Serology (Table 2)
- RHD*1154C (weak D type 2): Density
- RHD*17T (weak D type 31): Serology (Table 2)
- RHD*17T (weak D type 31): Density
- RHD*17T (weak D type 31): Prevalence
- RHD*17T (weak D type 31): Density
- RHD*17T (weak D type 31): otherHaplotype (family study of 2 samples)
- RHD*17T (weak D type 31): RH1
- RHD*17T (weak D type 31): RH1 (initially typed as D negative)
- RHD*26A (weak D type 26): Serology (Table 2)
- RHD*48C,602G,667G,819A (weak D type 4.1, DAR4): Serology (Table 2)
- RHD*48C,602G,667G,819A (weak D type 4.1, DAR4): Density
- RHD*48C,602G,667G,819A (weak D type 4.1, DAR4): otherHaplotype (2 samples used as controls, may have been included in other studies)
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): Density
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): Serology (Table 2)
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): otherHaplotype (1 sample used as control, may have been included in other studies)
- RHD*809G (weak D type 1): Density
- RHD*809G (weak D type 1): otherHaplotype (3 samples used as controls, may have been included in other studies)
- RHD*809G (weak D type 1): Serology (Table 2)
- RHD*845A (weak partial D type 15): Serology (Table 2)
- RHD*845A (weak partial D type 15): Density
- RHD*845A (weak partial D type 15): otherHaplotype (2 samples used as controls, may have been included in other studies)
- RHD*8G (weak D type 3): Serology (Table 2)
- RHD*8G (weak D type 3): otherHaplotype (2 samples used as controls, may have been included in other studies)
- RHD*8G (weak D type 3): Density
- RHD*D-cE(4-5)-D (DVI type 1): Serology (Table 2)
- RHD*D-cE(4-5)-D (DVI type 1): otherHaplotype (3 samples used as controls, may have been included in other studies)
- RHD*D-cE(4-5)-D (DVI type 1): Density
- RHD*D-CE(7:1048-7:1061)-D (DIV type 4): Serology (Table 2)
- RHD*D-CE(7:1048-7:1061)-D (DIV type 4): otherHaplotype (1 sample used as control, may have been included in other studies)
- RHD*D-CE(7:1048-7:1061)-D (DIV type 4): Density